カテゴリー： IMARC, 世界, 医療/バイオ

OTC人工涙液の世界市場2022-2028：産業動向、シェア、規模、成長、機会・予測

◆英語タイトル：OTC Artificial Tears Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

IMARCが発行した調査報告書（IMARC23FE0094）◆商品コード：IMARC23FE0094
◆発行会社（リサーチ会社）：IMARC
◆発行日：2023年2月1日
◆ページ数：147
◆レポート形式：英語 / PDF
◆納品方法：Eメール
◆調査対象地域：グローバル
◆産業分野：医薬品
◆販売価格オプション（消費税別）
Single UserUSD2,999 ⇒換算￥455,848見積依頼/購入/質問フォーム
Five UserUSD3,999 ⇒換算￥607,848見積依頼/購入/質問フォーム
EnterprisewideUSD4,999 ⇒換算￥759,848見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

IMARC社発行の当調査資料によると、2022年49億ドルであった世界のOTC人工涙液市場規模が2028年には64億ドルに達し、予測期間中、年平均5％成長すると予測されています。当書は、OTC人工涙液の世界市場について総合的に調査・分析されたレポートです。序論、範囲・調査手法、エグゼクティブサマリー、イントロダクション、製品別（溶液、軟膏、エマルジョン、ジェル、その他）分析、容器別（プラスチック製シングル用量容器、プラスチック製マルチ用量容器、その他）分析、製剤別（防腐剤、防腐剤不使用）分析、用途別（ドライアイ症候群、アレルギー、感染症、紫外線・ブルーライト対策、その他）分析、地域別（北米、アジア太平洋、ヨーロッパ、中南米、中東/アフリカ）分析、SWOT分析、バリューチェーン分析、ファイブフォース分析、価格分析、競争状況などの項目がまとめられています。なお、当書に掲載されている企業情報には、AbbVie Inc.、Akorn Inc.、Alcon、Bausch Health Companies Inc.、Johnson & Johnson、Nicox S.A.、OASIS Medical、OCuSOFT Inc.、Santen Pharmaceutical Co. Ltd.,Similasan Corporation、Sun Pharmaceutical Industries Ltd. and URSAPHARM Arzneimittel GmbH.などが含まれています。
・序論
・範囲・調査手法
・エグゼクティブサマリー
・イントロダクション

・世界のOTC人工涙液市場規模：製品別
- 溶液の市場規模
- 軟膏の市場規模
- エマルジョンの市場規模
- ジェルの市場規模
- その他製品の市場規模

・世界のOTC人工涙液市場規模：容器別
- プラスチック製シングル用量容器の市場規模
- プラスチック製マルチ用量容器の市場規模
- その他容器の市場規模

・世界のOTC人工涙液市場規模：製剤別
- 防腐剤OTC人工涙液の市場規模
- 防腐剤不使用OTC人工涙液の市場規模

・世界のOTC人工涙液市場規模：用途別
- ドライアイ症候群における市場規模
- アレルギーにおける市場規模
- 感染症における市場規模
- 紫外線・ブルーライト対策における市場規模
- その他用途における市場規模

・世界のOTC人工涙液市場規模：地域別
- 北米のOTC人工涙液市場規模
- アジア太平洋のOTC人工涙液市場規模
- ヨーロッパのOTC人工涙液市場規模
- 中南米のOTC人工涙液市場規模
- 中東/アフリカのOTC人工涙液市場規模

・SWOT分析
・バリューチェーン分析
・ファイブフォース分析
・価格分析
・競争状況
・主要企業情報

The global OTC artificial tears market size reached US$ 4.9 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 6.4 Billion by 2028, exhibiting a growth rate (CAGR) of 5% during 2023-2028.

Over the Counter (OTC) artificial tears are eye drops that are used for lubricating eyes and providing relief from pain, discomfort, burning, redness, photophobia and irritation in the eyes. They are manufactured using dextran, glycerin, propylene glycol, hydroxypropyl methylcellulose (HPMC) and carboxymethylcellulose. Artificial tears are widely used for the treatment of dry eyes, which is a medical condition when sufficient moisture or lubrication is not generated on the conjunctiva, cornea or entire surface of the eye. OTC artificial tears are biocompatible and aid in stabilizing the tear film, promoting healing and minimizing tear evaporation. In addition to this, OTC artificial tears are also available in ointment, spray, emulsion, solution and gel forms that are highly convenient use.

OTC Artificial Tears Market Trends:
The rising geriatric population that is prone to chronic eye-related disorders is one of the key factors driving the growth of the market. Due to the increasing prevalence of dry eye syndrome (DES), diabetes and nutritional deficiencies, there is a rising demand for OTC artificial tears to provide immediate relief from discomfort in the eyes. Additionally, the increasing utilization of electronics, such as smartphones, televisions (TVs) and laptops, leading to excessive screen time and eye fatigue, is positively impacting the adoption of OTC artificial tears. Various product innovations, such as the development of variants fortified with blink-activated coatings, are providing a thrust to the market growth. These coatings provide ocular hydration to patients suffering from evaporative dry eye syndrome. In line with this, the widespread product adoption with contact lenses to facilitate the flow of oxygen to the cornea and prevent dryness on the surface of the eyes is favoring the market growth. Other factors, including rising levels of pollution, especially in the urban regions, along with the increasing health consciousness among the masses, are anticipated to drive the market toward growth.

Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global OTC artificial tears market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product, container type, formulation, application and distribution channel.

Breakup by Product:

Solution
Ointment
Emulsion
Gel
Spray Solution
Suspensions

Breakup by Container Type:

Plastic Single Dose Container
Plastic Multi-Dose Container
Others

Breakup by Formulation:

Preservative Based
Non-Preservative Based

Breakup by Application:

Dry Eye Syndrome
Allergies
Infections
UV and Blue Light Protection
Contact Lens Moisture Retention
Others

Breakup by Distribution Channel:

Hospital Pharmacies
Drug Store and Retail Pharmacies
Online Pharmacies

Breakup by Region:

North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa

Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being AbbVie Inc., Akorn Inc., Alcon, Bausch Health Companies Inc., Johnson & Johnson, Nicox S.A., OASIS Medical, OCuSOFT Inc., Santen Pharmaceutical Co. Ltd., Similasan Corporation, Sun Pharmaceutical Industries Ltd. and URSAPHARM Arzneimittel GmbH.

Key Questions Answered in This Report
1. What was the size of the global OTC artificial tears market in 2022?
2. What is the expected growth rate of the global OTC artificial tears market during 2023-2028?
3. What are the key factors driving the global OTC artificial tears market?
4. What has been the impact of COVID-19 on the global OTC artificial tears market?
5. What is the breakup of the global OTC artificial tears market based on the product?
6. What is the breakup of the global OTC artificial tears market based on the container type?
7. What is the breakup of the global OTC artificial tears market based on formulation?
8. What is the breakup of the global OTC artificial tears market based on the application?
9. What is the breakup of the global OTC artificial tears market based on the distribution channel?
10. What are the key regions in the global OTC artificial tears market?
11. Who are the key players/companies in the global OTC artificial tears market?

❖ レポートの目次 ❖

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global OTC Artificial Tears Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Product
6.1 Solution
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Ointment
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Emulsion
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Gel
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Spray Solution
6.5.1 Market Trends
6.5.2 Market Forecast
6.6 Suspensions
6.6.1 Market Trends
6.6.2 Market Forecast
7 Market Breakup by Container Type
7.1 Plastic Single Dose Container
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Plastic Multi-Dose Container
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Others
7.3.1 Market Trends
7.3.2 Market Forecast
8 Market Breakup by Formulation
8.1 Preservative Based
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Non-Preservative Based
8.2.1 Market Trends
8.2.2 Market Forecast
9 Market Breakup by Application
9.1 Dry Eye Syndrome
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Allergies
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Infections
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 UV and Blue Light Protection
9.4.1 Market Trends
9.4.2 Market Forecast
9.5 Contact Lens Moisture Retention
9.5.1 Market Trends
9.5.2 Market Forecast
9.6 Others
9.6.1 Market Trends
9.6.2 Market Forecast
10 Market Breakup by Distribution Channel
10.1 Hospital Pharmacies
10.1.1 Market Trends
10.1.2 Market Forecast
10.2 Drug Store and Retail Pharmacies
10.2.1 Market Trends
10.2.2 Market Forecast
10.3 Online Pharmacies
10.3.1 Market Trends
10.3.2 Market Forecast
11 Market Breakup by Region
11.1 North America
11.1.1 United States
11.1.1.1 Market Trends
11.1.1.2 Market Forecast
11.1.2 Canada
11.1.2.1 Market Trends
11.1.2.2 Market Forecast
11.2 Asia-Pacific
11.2.1 China
11.2.1.1 Market Trends
11.2.1.2 Market Forecast
11.2.2 Japan
11.2.2.1 Market Trends
11.2.2.2 Market Forecast
11.2.3 India
11.2.3.1 Market Trends
11.2.3.2 Market Forecast
11.2.4 South Korea
11.2.4.1 Market Trends
11.2.4.2 Market Forecast
11.2.5 Australia
11.2.5.1 Market Trends
11.2.5.2 Market Forecast
11.2.6 Indonesia
11.2.6.1 Market Trends
11.2.6.2 Market Forecast
11.2.7 Others
11.2.7.1 Market Trends
11.2.7.2 Market Forecast
11.3 Europe
11.3.1 Germany
11.3.1.1 Market Trends
11.3.1.2 Market Forecast
11.3.2 France
11.3.2.1 Market Trends
11.3.2.2 Market Forecast
11.3.3 United Kingdom
11.3.3.1 Market Trends
11.3.3.2 Market Forecast
11.3.4 Italy
11.3.4.1 Market Trends
11.3.4.2 Market Forecast
11.3.5 Spain
11.3.5.1 Market Trends
11.3.5.2 Market Forecast
11.3.6 Russia
11.3.6.1 Market Trends
11.3.6.2 Market Forecast
11.3.7 Others
11.3.7.1 Market Trends
11.3.7.2 Market Forecast
11.4 Latin America
11.4.1 Brazil
11.4.1.1 Market Trends
11.4.1.2 Market Forecast
11.4.2 Mexico
11.4.2.1 Market Trends
11.4.2.2 Market Forecast
11.4.3 Others
11.4.3.1 Market Trends
11.4.3.2 Market Forecast
11.5 Middle East and Africa
11.5.1 Market Trends
11.5.2 Market Breakup by Country
11.5.3 Market Forecast
12 SWOT Analysis
12.1 Overview
12.2 Strengths
12.3 Weaknesses
12.4 Opportunities
12.5 Threats
13 Value Chain Analysis
14 Porters Five Forces Analysis
14.1 Overview
14.2 Bargaining Power of Buyers
14.3 Bargaining Power of Suppliers
14.4 Degree of Competition
14.5 Threat of New Entrants
14.6 Threat of Substitutes
15 Price Analysis
16 Competitive Landscape
16.1 Market Structure
16.2 Key Players
16.3 Profiles of Key Players
16.3.1 AbbVie Inc.
16.3.1.1 Company Overview
16.3.1.2 Product Portfolio
16.3.1.3 Financials
16.3.1.4 SWOT Analysis
16.3.2 Akorn Inc.
16.3.2.1 Company Overview
16.3.2.2 Product Portfolio
16.3.2.3 Financials
16.3.2.4 SWOT Analysis
16.3.3 Alcon
16.3.3.1 Company Overview
16.3.3.2 Product Portfolio
16.3.3.3 Financials
16.3.4 Bausch Health Companies Inc.
16.3.4.1 Company Overview
16.3.4.2 Product Portfolio
16.3.4.3 Financials
16.3.4.4 SWOT Analysis
16.3.5 Johnson & Johnson
16.3.5.1 Company Overview
16.3.5.2 Product Portfolio
16.3.5.3 Financials
16.3.5.4 SWOT Analysis
16.3.6 Nicox S.A.
16.3.6.1 Company Overview
16.3.6.2 Product Portfolio
16.3.6.3 Financials
16.3.7 OASIS Medical
16.3.7.1 Company Overview
16.3.7.2 Product Portfolio
16.3.8 OCuSOFT Inc.
16.3.8.1 Company Overview
16.3.8.2 Product Portfolio
16.3.9 Santen Pharmaceutical Co. Ltd.
16.3.9.1 Company Overview
16.3.9.2 Product Portfolio
16.3.9.3 Financials
16.3.9.4 SWOT Analysis
16.3.10 Similasan Corporation
16.3.10.1 Company Overview
16.3.10.2 Product Portfolio
16.3.11 Sun Pharmaceutical Industries Ltd.
16.3.11.1 Company Overview
16.3.11.2 Product Portfolio
16.3.11.3 Financials
16.3.11.4 SWOT Analysis
16.3.12 URSAPHARM Arzneimittel GmbH
16.3.12.1 Company Overview
16.3.12.2 Product Portfolio



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ OTC人工涙液の世界市場2022-2028：産業動向、シェア、規模、成長、機会・予測(OTC Artificial Tears Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • モノクローナル抗体の世界市場2022-2028：産業動向、シェア、規模、成長、機会・予測
  • エアロゾル冷媒の世界市場2023～2028：産業動向、シェア、規模、成長、機会・予測
  • 血液悪性腫瘍の世界市場2023～2028：産業動向、シェア、規模、成長、機会・予測
  • アルツハイマー病治療薬の世界市場2023～2028：産業動向、シェア、規模、成長、機会・予測
  • オッセオインテグレーションインプラントの世界市場2023～2028：産業動向、シェア、規模、成長、機会・予測

    • ◆H&Iグローバルリサーチのお客様（例）◆